Ozempic is a brand name for semaglutide, a medication used for the treatment of type 2 diabetes in adults
As GLP-1 therapies gained approval for obesity, prescribing began to diffuse beyond endocrinology into primary care, obesity medicine, and digital health platforms
This matches the convenience profile of semaglutide and tirzepatide, which researchers already prefer for adherence reasons
If prescribed, your $80 treatment plan includes: A prescription for 3 months of treatment A custom titration schedule (starting at 0.25 mg) Three months of expert medical care and follow-up Access to your dedicated doctor and care team any time References FDA Drug Label Once-Weekly Semaglutide in Adults with Overweight or Obesity Nutritional Priorities to Support GLP-1 Therapy for Obesity: A Joint Advisory From the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society Once-Weekly Semaglutide in Adolescents with Obesity Managing Adverse Effects of Incretin-Based Medications for Obesity Were saving time in peoples lives by making healthcare easier
Adjustments may be necessary to find the optimal dosage and approach
